Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Apellis Pharmaceuticals buy RudolfL

Start price
€52.04
03.04.22 / 50%
Target price
€69.00
03.04.23
Performance (%)
31.30%
End price
€68.33
24.08.22
Summary
This prediction ended on 24.08.22 with a price of €68.33. The BUY prediction by RudolfL for Apellis Pharmaceuticals saw massive gains of 31.30%. RudolfL has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Apellis Pharmaceuticals - - -
iShares Core DAX® -0.116% 1.953% 14.155%
iShares Nasdaq 100 -2.733% -1.273% 31.828%
iShares Nikkei 225® -1.721% 3.263% 12.922%
iShares S&P 500 -1.527% 0.194% 27.117%

Comments by RudolfL for this prediction

In the thread Apellis Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 31.30%
Target price 55.000
Change
Ends at 03.04.23

Buy mit Kursziel 55,0

Prediction Buy
Perf. (%) 31.30%
Target price 69.000
Change
Ends at 03.04.23

Kursziel geändert auf 69,0

In the thread Trading Apellis Pharmaceuticals
Prediction Buy
Perf. (%) 31.30%
Target price 69.000
Change
Ends at 03.04.23

Buy beendet